Evidence map›Paper›PMID 39991046›Full record

Trial reportFrontiers in endocrinology2024

Weight loss-independent changes in human growth hormone during water-only fasting: a secondary evaluation of a randomized controlled trial.

Benjamin D Horne, Jeffrey L Anderson, Heidi T May, Tami L Bair, Viet T Le, Leslie Iverson, Kirk U Knowlton, Joseph B Muhlestein

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01059760 (Expression of Longevity Genes in Response to Extended Fasting), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01059760 nacompletednot on this map

Expression of Longevity Genes in Response to Extended Fasting

TypeinterventionalSponsorIntermountain Health Care, Inc.Ran2010 to 2010Enrolled30ConditionsCardiovascular DiseaseArmsFasting First, Fed First
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Benjamin D HorneCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.
Jeffrey L AndersonCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.
Heidi T MayCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.
Tami L BairCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.
Viet T LeCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.
Leslie IversonCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.
Kirk U KnowltonCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.
Joseph B MuhlesteinCardiovascular Department, Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Water-only fasting for one day or more may provide health benefits independent of weight loss. Human growth hormone (HGH) may play a key role in multiple fasting-triggered mechanisms. Whether HGH changes during fasting are independent of weight loss and how basal HGH and HGH change relate to other fasting-induced changes are unknown. Methods: Apparently healthy individuals (N=30) were randomized by Latin square to begin two days with either 24-hour water-only fasting or a control of 24-hour Results: Baseline HGH had median 0.50 ng/mL for females (n=20) and 0.04 ng/mL for males (n=10), and correlated inversely with weight, glucose, insulin, and triglycerides and positively with changes in insulin and HOMA-IR. The 24-hour fasting-induced HGH change was uncorrelated with weight loss (r= 0.01, p=0.98), but correlated with changes in glucose, HGB, and IGF-1. The percent increase in HGH was greater (p<0.001) for lower (females ≤0.15 ng/mL, males ≤0.05 ng/mL) vs. higher baseline HGH (median: 1,225% vs. 50.3%, respectively). Subjects with lower baseline HGH had a trend to greater reduction of HOMA-IR (median: -6.15 vs. -1.35 for lower vs. higher HGH, respectively, p=0.08). Conclusions: Fasting increased HGH and the HGH changes were independent of weight loss. Basal HGH and fasting-induced HGH changes correlated inversely with cardiometabolic risk factors.Clinical Trial Registration: clinicaltrials.gov, identifier NCT01059760.

Indexed as

FastingHuman Growth HormoneWeight LossAdultBlood GlucoseFemaleHumansInsulinMaleMiddle AgedWaterYoung AdultBlood GlucoseHuman Growth HormoneInsulinWaterextended fastingintermittent fastingperiodic fastingprolonged fastingweight-loss

Identifiers

PMID39991046
PMCPMC11842881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.